AI offers promise in the realm of chronic disease management, including diabetes, obesity, and PCOS, but must be approached with caution.

ADP excels in human capital management with AI-driven innovation, strong market potential, and resilience against challenges.

Despite ambitions to streamline regulatory review, FDA’s Elsa platform has been prone to hallucinations, prompting internal scrutiny and questions about AI reliability and governance.

From racing circuits to research labs to the entrepreneurial world, Harmoko's path should serve as inspiration for those ...